Stocks and Investing Stocks and Investing
Mon, February 13, 2023
[ 12:00 AM ] - WOPRAI
Gregory Renza Maintained (ADCT) at Buy with Decreased Target to $12 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
David Bellinger Downgraded (AAP) to Hold and Decreased Target to $140 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Alexia Dogani Downgraded (ZIM) to Sell and Decreased Target to $15 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Leonardo Olmos Downgraded (ZENV) to Hold and Decreased Target to $1.3 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Mark Mahaney Upgraded (ZG) to Buy and Increased Target to $61 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Brian Gong Maintained (YY) at Strong Buy with Decreased Target to $45 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Mark Mahaney Upgraded (Z) to Buy and Increased Target to $61 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Lee Horowitz Maintained (BKNG) at Strong Buy on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
John Zamparo Maintained (ACB) at Hold with Decreased Target to $18 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Bill Katz Upgraded (AB) to Buy and Increased Target to $44 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
David Koning Maintained (ACN) at Hold and Held Target at $290 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Emily Bodnar Initiated (ACLX) at Strong Buy and Held Target at $42 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Mircea Dobre Downgraded (CAT) to Hold and Decreased Target to $230 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Zekauskas Maintained (CBT) at Buy with Increased Target to $87 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Christopher Kapsch Maintained (CBT) at Strong Buy with Increased Target to $113 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Chip Moore Initiated (atlx) at Strong Buy and Held Target at $12 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Sumeet Mody Maintained (ARES) at Buy with Increased Target to $97 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (ARES) at Hold with Increased Target to $88 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Neal Dingmann Maintained (AR) at Strong Buy with Decreased Target to $41 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Vikram Malhotra Maintained (ARE) at Strong Buy with Increased Target to $180 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Ravi Shanker Reiterated (ARCB) at Buy and Held Target at $138 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (APO) at Hold with Decreased Target to $68 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Brad Heffern Maintained (WPC) at Buy with Increased Target to $88 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Kuske Maintained (WFG) at Buy with Increased Target to $97 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Simeon Gutman Reiterated (WMT) at Buy and Held Target at $54 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Douglas Mitchelson Reiterated (WMG) at Buy and Held Target at $36 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Steve Sakwa Maintained (VTR) at Hold with Increased Target to $50 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Ygal Arounian Maintained (VRSN) at Strong Buy with Increased Target to $252 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Silvan Tuerkcan Reiterated (VOR) at Buy and Held Target at $12 on, Feb 13th, 2023
[ 12:00 AM ] - WOPRAI
Gregory Renza Upgraded (VRCA) to Buy and Increased Target to $11 on, Feb 13th, 2023

Gregory Renza Upgraded (VRCA) to Buy and Increased Target to $11 on, Feb 13th, 2023


Published on 2024-10-28 01:35:17 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Upgraded "Verrica Pharmaceuticals Inc." (VRCA) to Buy and Increased Target from $4 to $11 on, Feb 13th, 2023.

Gregory, nor any peers, have made any analyst calls on VRCA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources